Case Report: Anti-TNF Treatment Failure in a Patient With Immune Checkpoint Inhibitor-Induced Severe Colitis

Case Report: Anti-TNF Treatment Failure in a Patient With Immune Checkpoint Inhibitor-Induced Severe Colitis

Immune checkpoint inhibitor (ICI)-induced colitis is one of the known complications of therapies targeting cytotoxic programmed cell death protein 1 (PD-1), cytotoxic T lymphocyte-associated antigen 4 (CTLA-4), and programmed cell death ligand 1 (PD-L1). ICI-associated colitis is routinely treated w...

Celý popis

Podrobná bibliografie
Hlavní autoři: Leilei Fang, Changqin Liu, Xiaomin Sun, Zhanju Liu
Médium: Článek
Jazyk:English
Vydáno: Frontiers Media S.A. 2022-06-01
Edice:Frontiers in Oncology
Témata:
anti-tumor necrosis factor-α
colitis
durvalumab
immune checkpoint inhibitor
programmed cell death ligand 1
vedolizumab
On-line přístup:https://www.frontiersin.org/articles/10.3389/fonc.2022.925964/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2022.925964/full

Podobné jednotky